Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients
Titel:
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients
Auteur:
Schiaroli, Elisabetta Gidari, Anna Brachelente, Giovanni Bicchieraro, Giulia Spaccapelo, Roberta Bastianelli, Sabrina Pierucci, Sara Busti, Chiara Pallotto, Carlo Malincarne, Lisa Camilloni, Barbara Falcinelli, Flavio De Socio, Giuseppe Vittorio Villa, Alfredo Mencacci, Antonella Francisci, Daniela